Whereas both cell populations remained unaffected in the spleen (see Figure 1B and Supplementary Figure s1), treatment of A673 tumours with SZH9, clodrolip or with a combination of both reagents strongly reduced the CD11b+ cell population, whereas CD11c+ TADCs were completely eradicated (Figure 4A and B). Here, ITGAX is linked to neoplasm.